July 11, 2014 1:52 AM ET


Company Overview of S*BIO Pte Ltd.

Company Overview

S*BIO Pte Ltd., a biotech company, focuses on the discovery, research, and clinical development of small molecule drugs for the treatment of cancer in Singapore. The company’s pipeline comprises JAK2 inhibitors, such as SB1518 for leukemia/myelofibrosis, lymphoma, and polycythemia; and SB1578 for RA/psoriasis. Its pipeline also includes SB939, a histone deacetylases for MDS/AML+combo, prostate cancer, sarcoma, pediatric tumor, and myelofibrosis; SB2602, a mTOR inhibitor; SB2343, a mTOR/PI3K inhibitor; and SB1317, a CDK/Flt3 inhibitor. The company was founded in 2000 and is based in Singapore. S*BIO Pte Ltd. operates as a subsidiary of Chiron Corporation Limited.

1 Science Park Road

#05-09 The Capricorn

Singapore Science Park II

Singapore,  117 528


Founded in 2000


65 6827 5000


65 6827 5005

Key Executives for S*BIO Pte Ltd.

Interim Chief Executive Officer and Director
Age: 65
Consulting Vice President of Business Development
Director of Corporate Development
Medical Advisor
Age: 61
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cell Sciences Pte Ltd. Asia
SG Austria Pte. Ltd. Asia
Pharmalogicals Research Pte. Ltd. Asia
Compass Foods Pte Ltd Asia
EPIC Bio Pte. Limited Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact S*BIO Pte Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.